Severe combined immunodeficiency (SCID) is a fatal genetic disorder and one of the common genetic diseases of the Arabian horse. The genetic mutation responsible for this disease is a five base pair deletion (TCTCA) in the DNA-protein kinase catalytic subunit gene. Severe combined immunodeficiency is a recessive autosomal genetic disorder with 25% chance inheritance of the disease among the progeny of carrier parents. It causes complete absence of certain immune cells, like B and T lymphocytes, leaving foals with immunodeficiency and exposing them to early death within 4 to 6 months. This study aimed to establish a reliable DNA test for detection of asymptomatic SCID carriers in the Egyptian Arabian horse population and to re-examine cases of unexplained foal death to exclude presence of SCID disease. Samples collected from live horses were chosen at random from the registered population, as well as postmortem samples from reported cases died at different ages in Arabian farms. Among these samples, we did not identify SCID carriers. Improved SCID diagnostic assays will help in selection within breeding programs to avoid carrier-to-carrier mating and the birth of clinically affected foals. This will have a positive effect on the financial value of Arabian horse production by decreasing economic losses due to affected foal deaths, extended veterinary care, and intensive but futile treatments. Application of the DNA test overall Egyptian population is recommended.
Introduction
Severe combined immunodeficiency (SCID) disease is identified as a genetic disorder of humans [1] , horses [2] , dogs [3] , and mice [4] . Equine SCID primarily affects Arabian horses and their crossbreeds [5] . It is an autosomal recessive genetic disorder [6] characterized by severe loss of immune cells like T-and B-lymphocytes leaving individual with an insufficient immune response [7] . Severe combined immunodeficiency is caused by a five base pair deletion mutation in (TCTCA) in the DNA-protein kinase catalytic subunit gene, which is located in chromosome 9 [8] . Affected foals are clinically normal at birth for 1e3 months of age due to maternal passively transferred immunity; however, after acquired maternal antibodies drop under the level of protection, foals become severely susceptible to opportunistic infections that normal foals can easily resist [9] . Most SCID foals die by 5 months of age despite intensive veterinary care [10] . An SCID diagnosis can be inferred by clinical and laboratory findings, but such an approach is inaccurate as SCID clinical signs share similarities with many diseases [11] and [12] . Thus, misdiagnosis occurs frequently. DNA testing is very important to detect heterozygous individuals, as carrier individuals do not show any clinical signs [13] . Accurate identification of carriers is a key for avoidance of carrier-to-carrier matings and the birth of clinically affected foals [9] . Existing DNA tests for detection of equine SCID identify the five base pair deletion in the DNA-protein kinase catalytic subunit gene. Polymerase chain reaction is typically performed using specific forward and reverse primers flanking the deletion site that produce amplified fragments that differentiate the wild-type and SCID alleles based on the size difference [5] . The main aim of this study was establishment of an accurate assay for screening of SCID genotypes in Arabian horses in Egypt.
Materials and Methods

Samples
No equids were euthanized for the purpose of this study. Total 103 samples were tested based on four groups. 
DNA Extraction
Total DNA extraction was performed from internal organs in postmortem cases and from hair follicles in samples from live horses using EZ-10 Spin Genomic DNA Miniprep kit for Animal tissue (Bio Basic Inc., Canada) according to the manufacturer's protocols.
Polymerase Chain Reaction
Polymerase chain reaction was performed using Applied Biosystems AmpliTaq Gold 360 Buffer Kit (Applied Biosystems, Thermo Fisher Scientific, Waltham, MA) with using set of primers flanking the five base deletion site [5] .
Forward primer: 5 0 -AAG TTG GTC TTG TCA TTG AGC-3 0 Reverse primer: 5 0 -TTT GTG ATG ATG TCA TCC CAG-3 0
Fragment Analysis
Reaction optimization was carried out using a known control carrier. Polymerase chain reaction was carried out using Applied Biosystems AmpliTaq Gold 360 Buffer Kit using different primers and DNA concentrations. Polymerase chain reaction was performed in thermal cycler (BioRad, Hercules, California, USA) with the following conditions: initial denaturation 95 C for 10 minutes followed by 30 cycles of 95 C denaturation for 40 seconds, 60 C annealing for 1 minute, and 72 C extension for 30 seconds with 72 C final extension for 10 minutes.
The amplified fragments then loaded with Hi-Di Formamide and GeneScan 500 LIZ dye Size Standard (Applied Biosystems, Thermo Fisher Scientific, Waltham, MA, USA) and separated on 3500 Genetic Analyzer and the generated data will be analyzed with GeneMapper software v4.1.
Unlabeled DNA amplicons were purified from gel using GeneJET Gel Extraction Kit for further Sequencing using BigDye Terminator Cycle Sequencing Kit. Processing of the sequence reaction in Genetic analyzer 3500 (Applied Biosystem, USA).
DNA sequence analysis was performed with DNA Sequencing Analysis Software (Applied Biosystem, USA).
Results
Specific PCR amplicons (161e166 bp) of the SCID region were detected by agarose gel electrophoresis (Fig. 1) .
Based on agarose gel electrophoresis, we were not able to detect the five base pairs deletion difference between homozygous and heterozygous animals. Control positive sample is run alongside with all tested samples to confirm accuracy of the assay. One pattern is found in both cases (Fig. 1) .
In sequence analysis, the candidate five base pairs in protein kinase catalytic subunit gene were present in all tested samples (Fig. 2) ; No carrier individuals were found. DNA sequence samples are deposited in GeneBank with accession numbers; MG674282, MG674283, and MG674284.
In fragment analysis using labeled forward primer, control positive carrier showed two alleles different in size, first allele found in the size of 161 bp represented the mutant allele, whereas the other allele is in the size of 166 bp represented the wild-type allele. All tested samples were homozygous at the size of 166 bp (Fig. 3) . 
Discussion
In our study, agarose gel electrophoresis was utilized to confirm the efficiency and specificity of primers. Yet, this approach is unreliable for SCID diagnosis, as it cannot differentiate the small size difference between amplicons of the normal and the SCID allele. In fragment analysis, the pattern of peak generated from the wildtype allele was easily observed at the expected size of 166 bp, whereas the mutant allele measures just 161 bp. The pattern of peaks for the carrier control positive was heterozygous of two peaks, the wild-type and the mutant allele. Total examined samples in this study showed single peak pattern at the size 166 bp. Our samples proved to be free of the SCID allele; however, further investigation is necessarily required to exclude the possibility of This DNA test should be applied to all Arabian horses utilized in breeding, not only individuals related to an affected foal. The policy of some breeders to test only the related carriers allows transmittance of the mutant allele to future generations [14] . Most breeders allow individuals to breed without genetic testing because most genetic disorders carriers are of silent symptoms as genetic diseases, which often have a recessive mode of inheritance, are difficult to be recognized phenotypically.
Moreover, SCID is considered a primary but masked cause of clinical signs, as the clinical symptoms are a result of the secondary, but lethal, infectious disease. Ultimately, SCID cannot be directly observed in the population and the only way to detect this disease is making DNA test screening to all the populations of Arabian horses to eliminate the mutant allele. Severe combined immunodeficiency allele was previously observed in many countries. The frequency of SCID carriers in the United States was 25.7%, with 2%e 3% of the population representing affected homozygous foals [15] . After application of the DNA test, the frequency of carriers decreased dramatically to 8.4% with just 0.18% affected foals [16] . The frequency of carriers in the UK was evaluated to be between 1% and 5% [5] . The carriers' frequency in Brazil was 1.5% [17] and in Morocco was 7% [18] . The frequency of SCID carriers in Arabian horses found in South Africa in 2004 and 2009 was proven to be 6.4% and 3.4%, respectively [19] . Severe combined immunodeficiency carriers were absent in Poland [20] , Slovenia [21] , and Turkey [13] .
Conclusion
The probability of presence of the mutant allele in the Egyptian population is very low based on results gained by testing group of highly suspected samples and presented in this study. In addition, SCID allele was absent in Arabian stallions of Egyptian origin introduced into Poland [22] .
Arabian horse populations are affected by a number of genetic defects [10] . The absence of organized selective breeding systems and industry dependence on phenotypic characteristics rather than genotypic ones allows for continued perpetuation of these alleles. Moreover, the lack of awareness of genetic conditions among breeders and veterinarians leads to increases in the frequency of deleterious traits within breeding stock. The aims of this study were (1) establishment of a DNA testing capacity for diagnosis of SCID and (2) application of this test for detection of SCID carriers in Egyptian Arabian horses. Our long-term goal is to enable avoidance of carrier-to-carrier matings and the birth of clinically affected foals.
We recommend applying this diagnostic test in a periodic survey of the Egyptian Arabian horse population and in excluding an SCID diagnosis among cases of unexplained foal death.
